文献速递造血干细胞移植与细胞治疗淋巴瘤

肽结合基序对接受移植后环磷酰胺的HLA单倍体相合移植生存的影响

Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamide.
PubMed 文献 · Br J Haematol · 2024-07-07

该回顾性研究利用国家登记数据纳入1352例接受移植后环磷酰胺的HLA单倍体相合造血细胞移植患者,分析肽结合基序(PBM)错配对结局的影响。多变量分析显示PBM-A双向错配与总体死亡率风险升高相关(HR 1.26,95%CI 1.06-1.50,p=0.010),全队列中复发、非复发死亡(NRM)及移植物抗宿主病按PBM-A双向错配状态均无显著差异。

要点

  • PBM-A双向错配与总体死亡率风险升高相关(HR 1.26,95%CI 1.06-1.50,p=0.010)。
  • 全队列中复发、NRM及GVHD按PBM-A双向错配状态均无显著差异。
  • 在淋巴系统恶性肿瘤接受减低强度预处理者中,PBM-A双向错配因高NRM导致更差OS更为突出。

核心结论

  • 本研究表明PBM-A双向错配的存在升高了PTCy-haplo的死亡风险。
  • 避免PBM-A双向错配可能获得更好的PTCy-haplo结局。

研究设计与样本

  • 回顾性研究,使用国家登记数据,纳入接受PTCy-haplo的1352例患者。

主要发现

  • 多变量分析中PBM-A双向错配与总体死亡率风险升高相关(HR 1.26,95%CI 1.06-1.50,p=0.010)。
  • 全队列中复发、NRM及GVHD按PBM-A双向错配状态均无显著差异。
  • PBM-A双向错配对OS的影响在HLA-A基因型双向错配人群中仍然存在,该人群较低的OS源于较高的复发率。
  • 在淋巴系统恶性肿瘤接受减低强度预处理者中,PBM-A双向错配因高NRM导致更差OS更为突出。

临床怎么用

  • 原文结论指出避免PBM-A双向错配可能获得更好的PTCy-haplo结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Peptide-binding motif (PBM) model, a hierarchical clustering of HLA class I based on their binding specificity, was developed to predict immunopeptidome divergence. The effect of PBM mismatches on outcomes is unknown in HLA-haploidentical haematopoietic cell transplantation with post-transplant cyclophosphamide (PTCy-haplo). We therefore conducted a retrospective study using national registry data in PTCy-haplo. Overall, 1352 patients were included in the study. PBM-A bidirectional mismatch was associated with an increased risk of overall mortality in multivariable analysis (hazard ratio, 1.26; 95% confidence interval, 1.06 to 1.50; p = 0.010). None of relapse, non-relapse mortality (NRM) and graft-versus-host disease showed significant differences according to PBM-A bidirectional mismatch status in the entire cohort. The impact of PBM-A bidirectional mismatch on overall survival (OS) was preserved within the HLA-A genotype bidirectional mismatch population, and their lower OS stemmed from higher relapse rate in this population. The worse OS due to high NRM with PBM-A bidirectional mismatch was prominent in lymphoid malignancies receiving reduced-intensity conditioning. The PBM model may predict outcomes more accurately than HLA genotype mismatches. In conclusion, this study demonstrated that the presence of PBM-A bidirectional mismatch elevated the risk of mortality of PTCy-haplo. Avoiding PBM-A bidirectional mismatch might achieve better outcomes in PTCy-haplo.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Ido K, Nakamae H, Hattori N, et al. Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamide. Br J Haematol. 2024. PMID: 38972374. doi:10.1111/bjh.19630

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。